Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 20 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-24 4 AS $80.00 $160,000 I/I (2,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-09-28 4 AS $40.20 $160,804 D/D (4,000) 177,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-14 4 OE $21.51 $172,080 D/D 8,000 335,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-02-23 4 S $35.31 $176,541 D/D (5,000) 121,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 AS $88.73 $177,462 D/D (2,000) 227,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-07 4 AS $35.96 $179,800 D/D (5,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-25 4 AS $90.00 $180,000 I/I (2,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-05 4 AS $36.53 $182,729 D/D (5,000) 3,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-06-01 4 AS $18.18 $183,293 D/D (10,000) 13,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-14 4 AS $92.64 $185,280 D/D (2,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-18 4 OE $26.49 $185,430 D/D 7,000 302,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-19 4 OE $26.49 $185,430 D/D 7,000 302,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-11 4 OE $26.49 $185,430 D/D 7,000 302,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-12 4 OE $26.49 $185,430 D/D 7,000 302,652 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-12 4 AS $93.12 $186,240 D/D (2,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 OE $37.46 $187,300 D/D 5,000 339,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-01-09 4 AS $94.14 $188,286 D/D (2,000) 225,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-21 4 S $126.10 $189,157 I/I (1,500) 31,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-10 4 AS $95.00 $190,000 I/I (2,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-27 4 AS $48.34 $193,360 D/D (4,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-11-14 4 S $48.50 $193,987 D/D (4,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 OE $12.99 $194,850 I/I 15,000 35,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-09 4 OE $12.99 $194,850 I/I 15,000 57,279 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 20 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us